120 related articles for article (PubMed ID: 8831896)
1. Inhibition of macrophage nitric-oxide production and Ia-expression by docosahexaenoic acid, a constituent of fetal and neonatal serum.
Khair-el-Din TA; Sicher SC; Vazquez MA; Lu CY
Am J Reprod Immunol; 1996 Jul; 36(1):1-10. PubMed ID: 8831896
[TBL] [Abstract][Full Text] [Related]
2. Docosahexaenoic acid, a major constituent of fetal serum and fish oil diets, inhibits IFN gamma-induced Ia-expression by murine macrophages in vitro.
Khair-el-Din TA; Sicher SC; Vazquez MA; Wright WJ; Lu CY
J Immunol; 1995 Feb; 154(3):1296-306. PubMed ID: 7822798
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid, a constituent of fetal and neonatal serum, inhibits nitric oxide production by murine macrophages stimulated by IFN gamma plus LPS, or by IFN gamma plus Listeria monocytogenes.
Lu CY; Penfield JG; Khair-el-Din TA; Sicher SC; Kielar ML; Vazquez MA; Che L
J Reprod Immunol; 1998 Apr; 38(1):31-53. PubMed ID: 9616876
[TBL] [Abstract][Full Text] [Related]
4. Docosahexaenoic acid, a constituent of rodent fetal serum and fish oil diets, inhibits acquisition of macrophage tumoricidal function.
Dustin LB; Shea CM; Soberman RJ; Lu CY
J Immunol; 1990 Jun; 144(12):4888-97. PubMed ID: 2141046
[TBL] [Abstract][Full Text] [Related]
5. Transcription of the murine iNOS gene is inhibited by docosahexaenoic acid, a major constituent of fetal and neonatal sera as well as fish oils.
Khair-El-Din T; Sicher SC; Vazquez MA; Chung GW; Stallworth KA; Kitamura K; Miller RT; Lu CY
J Exp Med; 1996 Mar; 183(3):1241-6. PubMed ID: 8642266
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid, a component of fish oil, inhibits nitric oxide production in vitro.
Jeyarajah DR; Kielar M; Penfield J; Lu CY
J Surg Res; 1999 May; 83(2):147-50. PubMed ID: 10329109
[TBL] [Abstract][Full Text] [Related]
7. Prolonged lipopolysaccharide inhibits leukotriene synthesis in peritoneal macrophages: mediation by nitric oxide and prostaglandins.
Brock TG; McNish RW; Mancuso P; Coffey MJ; Peters-Golden M
Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):131-45. PubMed ID: 14518557
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of macrophage nitric oxide production by arachidonate-cascade inhibitors.
Ryoyama K; Nomura T; Nakamura S
Cancer Immunol Immunother; 1993 Nov; 37(6):385-91. PubMed ID: 7694796
[TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress.
Komatsu W; Ishihara K; Murata M; Saito H; Shinohara K
Free Radic Biol Med; 2003 Apr; 34(8):1006-16. PubMed ID: 12684085
[TBL] [Abstract][Full Text] [Related]
10. Induction and modulation of macrophage Ia antigen expression by platelet-activating factor.
Erickson KL; Howard AD; Hubbard NE
J Leukoc Biol; 1997 Dec; 62(6):845-51. PubMed ID: 9400826
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of macrophage Ia expression by nitric oxide.
Sicher SC; Vazquez MA; Lu CY
J Immunol; 1994 Aug; 153(3):1293-300. PubMed ID: 8027556
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling.
Norris PC; Dennis EA
Proc Natl Acad Sci U S A; 2012 May; 109(22):8517-22. PubMed ID: 22586114
[TBL] [Abstract][Full Text] [Related]
13. Effects of six diterpenes on macrophage eicosanoid biosynthesis.
de las Heras B; Abad MJ; Silván AM; Pascual R; Bermejo P; Rodríguez B; Villar AM
Life Sci; 2001 Dec; 70(3):269-78. PubMed ID: 12005260
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib, a COX-2 inhibitor, synergistically potentiates the anti-inflammatory activity of docosahexaenoic acid in macrophage cell line.
Kondreddy VK; Kamatham AN
Immunopharmacol Immunotoxicol; 2016; 38(2):153-61. PubMed ID: 26954392
[TBL] [Abstract][Full Text] [Related]
15. Effects of prostaglandin E2 and nitric oxide inhibitors on the expression of interleukin-10, interleukin-12 and MHC class-II molecules in Mycobacterium microti-infected and interferon-gamma-treated mouse peritoneal macrophages.
Mittal J; Dogra N; Vohra H; Majumdar S
Folia Microbiol (Praha); 2001; 46(3):259-64. PubMed ID: 11702410
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of the mechanism for the anti-inflammatory effect of the anti-rheumatic drug auranofin].
Yamashita M
Yakugaku Zasshi; 2000 Mar; 120(3):265-74. PubMed ID: 10723268
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by auranofin of the production of prostaglandin E2 and nitric oxide in rat peritoneal macrophages.
Yamashita M; Ichinowatari G; Yamaki K; Ohuchi K
Eur J Pharmacol; 1999 Mar; 368(2-3):251-8. PubMed ID: 10193662
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 induction in macrophages is modulated by docosahexaenoic acid via interactions with free fatty acid receptor 4 (FFA4).
Li X; Yu Y; Funk CD
FASEB J; 2013 Dec; 27(12):4987-97. PubMed ID: 24005906
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism.
Harizi H; Juzan M; Moreau JF; Gualde N
J Immunol; 2003 Jan; 170(1):139-46. PubMed ID: 12496393
[TBL] [Abstract][Full Text] [Related]
20. Cytokine modulation of immune activation associated suppression of macrophage cyclooxygenase activity in vivo.
Beckerman KP; Schreiber RD; Needleman P
Prostaglandins Leukot Essent Fatty Acids; 1992 Nov; 47(3):231-8. PubMed ID: 1475281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
